NCT06273007 Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach
| NCT ID | NCT06273007 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Haramaya Unversity |
| Condition | Stillbirth |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2023-06-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Overall Objective To introduce PartoMa approach (locally agreed and achievable intrapartum guidelines and a continual in-house training program) to Ethiopian context through continuous fetal heart rate (FHR) monitoring using MOYO device and co-creation of context specific intrapartum care guideline for improving decision making in intrapartum care in Eastern Ethiopia. Interventions 1. Locally agreed and achievable intrapartum guidelines 2. Low dose high frequency trainings (LDHF) 3. Partograph Overall Design A quasi-experimental pre-post study (PartoMa study) Setting Department of Obstetrics and Gynaecology Haramaya Hospital and Hiwot Fana University Hospital, Ethiopia. Population Laboring women delivering at the study site from February 2023 to March 2025 and their offspring, as well as health providers. Women and their offspring will be enrolled at/after onset of labour and followed until discharge. Endpoints The primary endpoint is perinatal mortality. For further description and secondary outcomes, please see below. Study Time Data collection from June 2023 to May 2025. Specific Objectives i. To assess FHR monitoring practice and use of obstetric guideline for decision making in Hiwot Fana University Hospital ii. To improve feto-maternal outcome through applying PartoMa approach in Hiwot Fana University Hospital. iii. To determine the feasibility, acceptability and sustainability of low-dose high frequency trainings and PartoMa seminars in Hiwot Fana University Hospital. iv. To document changes in pregnancy outcomes after the introduction of PartoMa approaches-seminars, low dose high frequency trainings, continuous FHR monitoring and tailored interventions-in Hiwot Fana University Hospital. Setting PartoMa Ethiopia will be implemented at Haramaya General Hospital and Hiwot Fana Comprehensive Specialized University Hospital, which are both busy maternity units in Eastern Ethiopia. Both are government hospitals with an annual delivery number of around 5,000.
Eligibility Criteria
Inclusion Criteria: * All women in labour delivering at the study site and their outcome, July - September 2023 and July -September 2025 * All birth attendant at the study site in obstetrics and gynecology departments during the baseline and intervention period, July - September 2023 and July -September 2025 Exclusion Criteria: * NA
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06273007 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Stillbirth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06273007 currently recruiting?
Yes, NCT06273007 is actively recruiting participants. Contact the research team at daberaf@gmail.com for enrollment information.
Where is the NCT06273007 trial being conducted?
This trial is being conducted at Harar, Ethiopia, Harar, Ethiopia.
Who is sponsoring the NCT06273007 clinical trial?
NCT06273007 is sponsored by Haramaya Unversity. The trial plans to enroll 500 participants.